Technology & Industry

Evidence brief: Field evaluation of drone and AI assisted larval source management in Ghana

A sourced PLOS One study, published 2026-02-04. Read the researchers’ findings, methods and context, with links to connected African health evidence.

Healthcare professionals reviewing information at a workstation
Illustrative stock photograph from Unsplash. It does not depict the reported event, study participants or a confirmed Kenyan facility. Source: https://images.unsplash.com/photo-1576091160399-112ba8d25d1d

Published in PLOS One on 2026-02-04, this study is presented as an attributed evidence briefing. The excerpts below are the original researchers’ words, reproduced under their Creative Commons Attribution licence. Health Signal has selected the abstract and, where needed, opening background paragraphs; the complete methods, results, limitations and references remain in the linked paper.

Original authors: Godfred A Bokpin, Francis A Adzei, Samuel Dadzie, Masaki Umeda, Juhoe Kim, Himmat Singh

Source: PLOS One • DOI 10.1371/journal.pone.0340690

Read the complete primary study ↗ · Creative Commons Attribution licence

From the researchers

Abstract

Malaria remains a major public health burden in sub-Saharan Africa. In Ghana, in particular, larval source management (LSM) is increasingly recognized as a complementary vector control strategy. This study evaluates a field-adapted LSM approach that integrates drone-based mapping and artificial intelligence (AI)–driven site prioritization to enhance operational efficiency and reduce resource use.

The intervention replaces conventional manual scouting with aerial mapping conducted one day prior to larvicide application. An AI model analyzes geospatial and morphological features of water bodies to identify high-risk larval habitats. Site coordinates are transmitted to field teams via mobile devices for targeted treatment. A comparative field trial was conducted in eight administrative sub-districts within Ghana’s Eastern Region. Four sub-districts implemented the drone- and AI-assisted approach, while four served as controls using standard LSM procedures. A mixed-methods evaluation was employed, incorporating quantitative metrics and qualitative field insights.

Drone-assisted mapping led to more than a threefold increase in the number of identified breeding sites. AI-based targeting reduced larvicide consumption by over 60%. The combined technologies lowered worker requirements by approximately 50%. Despite these reductions, malaria case trends in the intervention sub-districts remained comparable to those in the control sub-districts. The study’s limitations include its restriction to the dry season and below-average rainfall, which may have influenced mosquito abundance and transmission.

Drone- and AI-assisted LSM demonstrated substantial resource savings without compromising vector control outcomes. Further longitudinal evaluation across transmission seasons is warranted to assess sustained effectiveness and inform national policy.

Introduction

Global efforts to control malaria have long relied on integrated vector management strategies, including long-lasting insecticidal nets (LLINs), indoor residual spraying (IRS), and prompt treatment of clinical cases [1–3]. Yet, malaria remains a significant global health threat. In 2023, an estimated 263 million cases and 597000 deaths were reported across 85 countries, with sub-Saharan Africa accounting for approximately 94% of all cases and 95% of deaths [4–6]. The burden disproportionately affects vulnerable populations, particularly children under five and pregnant women, while socioeconomic and geographic inequities further exacerbate barriers to access. Children from the poorest households in sub-Saharan Africa are five times more likely to be infected than those from wealthier households [5].

Despite intensified global action, recent trends show stagnation in malaria control, threatening the achievement of Sustainable Development Goal 3 targets. In response, the WHO’s Global Technical Strategy for Malaria 2016–2030 aims to reduce incidence and mortality by 90% by 2030 through three pillars: scaling up responses, increasing investment, and promoting innovation. One such innovation is larval source management (LSM), which targets mosquito breeding sites through larviciding, environmental manipulation, and habitat modification [7,8]. LSM also includes biological control agents such as larvivorous fish. Gambusia affinis has long been recognized as an efficient predator of mosquito larvae in permanent aquatic habitats, and in Ghana, studies have examined the prey selectivity and captive-breeding feasibility of the native lampeye killifish (Aplocheilichthys spilauchen) for potential use in mosquito biocontrol [9,10]. However, in large-scale LSM targeting densely populated areas, many breeding sites are temporary pools where fish cannot survive, making wide-scale deployment of fish neither practical nor sustainable.

Reading this evidence

Use the full paper to check the study design, participant selection, comparator and outcome definitions before drawing a practical conclusion. An association does not by itself show cause and effect. A reported performance measure needs its denominator and uncertainty. A finding from a particular facility, sample or time period should retain that scope when it is discussed elsewhere.

This briefing makes the source accessible within the wider technology & industry desk. It does not assess an individual patient or certify a product. When considering relevance to another health system, examine the original authors’ account of context and limitations, then seek local implementation evidence. The related reporting below provides other studies to read alongside this one; it is a topic connection, rather than a claim that their results are directly comparable.

© 2026 Godfred A Bokpin, Francis A Adzei, Samuel Dadzie, Masaki Umeda, Juhoe Kim, Himmat Singh. Excerpts reproduced under CC BY. Selection, formatting and contextual notes by Health Signal. The researchers are the authors of the source study, not members of Health Signal’s staff.

Explore connected evidence

Health Signal Editorial Desk

Health Signal’s publication desk curates source-based health analysis and attributed research briefings. Study authors and originating institutions are credited within each article. Preparation used AI assistance; source and licence checks do not constitute independent replication or clinical endorsement.

More from this writer ↗